Senior Health link

Menu
CHAT GPT
YAHOO
YAHOO
X
YOUTUBE
Menu

MMWR

Highly Pathogenic Avian Influenza A(H5N1) Virus Infection in a Child with No Known Exposure – San Francisco, California, December 2024-January 2025

September 8, 2025 6:07 am Published by Comments Off on Highly Pathogenic Avian Influenza A(H5N1) Virus Infection in a Child with No Known Exposure – San Francisco, California, December 2024-January 2025

This report describes a case of highly pathogenic avian influenza A(H5N1) identified in a school-aged child in California with no... View Article


Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices – United States, 2025-26 Influenza Season

September 1, 2025 10:34 am Published by Comments Off on Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices – United States, 2025-26 Influenza Season

This report describes the Advisory Committee on Immunization Practices’ updated seasonal flu vaccination recommendations for 2025-26 flu season.. Learn More


Use of Clesrovimab for Prevention of Severe Respiratory Syncytial Virus-Associated Lower Respiratory Tract Infections in Infants: Recommendations of the Advisory Committee on Immunization Practices – United States, 2025

September 1, 2025 10:34 am Published by Comments Off on Use of Clesrovimab for Prevention of Severe Respiratory Syncytial Virus-Associated Lower Respiratory Tract Infections in Infants: Recommendations of the Advisory Committee on Immunization Practices – United States, 2025

This report describes CDC’s recommendation for use of clesrovimab for prevention of severe respiratory syncytial virus (RSV) in infants. Learn... View Article


Respiratory Syncytial Virus Immunization Coverage Among Infants Through Receipt of Nirsevimab Monoclonal Antibody or Maternal Vaccination – United States, October 2023-March 2024

August 25, 2025 3:04 am Published by Comments Off on Respiratory Syncytial Virus Immunization Coverage Among Infants Through Receipt of Nirsevimab Monoclonal Antibody or Maternal Vaccination – United States, October 2023-March 2024

This report describes an analysis of infants born from October 2023-March 2024 that had respiratory syncytial virus (RSV) immunization coverage... View Article


  • Hello 👋, how can I help you today?
Gathering thoughts.. ...
AI Search
Chat Icon